Navigation Links
Pharma IQ's Drug Recalls Industry Outline
Date:8/24/2012

LONDON, August 24, 2012 /PRNewswire/ --

Pharma IQ has just produced the Drug Recalls Industry Outline, where it analyses the challenges and implications of the late stage development failures. Pharma IQ had a quick look back over the last few years to see a timeline of drug failures and recalls at the late stages of development.

'Some of the key time saving strategies and information sources to make these decisions are trial design approaches, imaging techniques, biomarkers, strategic outsourcing and patient recruitment' says Nicola Ambler, Senior Conference Director, Pharma IQ, who is directing the upcoming Innovation in Phase 1 Clinical Development in Milan this September.

The outline analyses the drug withdrawals in the latter stages. In August 2012, Pfizer and J&J announced they were going to stop the development of the Alzheimer's drug, Bapineuzumab.  In March 2012 AstraZeneca and Targacept announced that their partnered depression drug - TC-5214 - failed at Phase III. The last two of four late-stage studies failed to meet their primary endpoints, eliminating plans for a comeback after the first two Phase III studies also ended in failure. In March 2011 Sanofi-Aventis' lung cancer drug aflibercept failed to meet its primary endpoint in a phase III trial.

The Drug Recalls Industry Outline can be accessed at http://www.phase1clinicaldevelopment.com/news

The Industry Outline was created as a part of the pre-conference preparation for the 3th Innovation in Phase I Clinical Development Forum taking place 17-19 September, 2012 in Milan. The agenda and final speaker line-up feature JW McBlane, Pharmaceutical Assessor, MHRA that will lead the session Early Clinical Studies - A Regulator's Expectations for Complex Protocols a
'/>"/>

SOURCE Pharma IQ
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 With herbal medicines relied upon by ... U.S. Pharmacopeial Convention (USP) will provide freely available public ... ingredients used in these products. Today, USP proposes the ... Herbal Medicines Compendium ( HMC ) for ... hmc.usp.org . HMC will provide standards ...
(Date:5/19/2013)... May 20, 2013 Claret Medical, Inc. announced the ... Van Mieghem et al., Histopathology of Embolic ... of print in Circulation, May 7 th this research ... Rotterdam, the Netherlands and the pathology ... the Cardiovascular Pathology Institute, Gaithersburg, Maryland.  This ...
(Date:5/19/2013)... May 20, 2013  Whole-cell pertussis vaccines were more ... during a large recent outbreak, according to a new ... pertussis vaccines, also called DTwP, were available from the ... that ultimately led to the development of acellular pertussis ... 1990s, the United States had ...
Breaking Medicine Technology:New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4
... 9, 2011 PDL BioPharma, Inc. (PDL) (NASDAQ: ... third quarter ended September 30, 2011. (Logo: ... third quarter of 2011 were $83.8 million, compared to $86.4 ... year-over-year decrease. Total revenues for the nine months ended September ...
... Nov. 9, 2011 Volcano Corporation (NASDAQ: ... guidance therapy tools designed to enhance the treatment of ... Intravascular Ultrasound (IVUS) and Fractional Flow Reserve (FFR) technologies ... patients undergoing percutaneous coronary intervention (PCI). The update was ...
Cached Medicine Technology:PDL BioPharma Announces Third Quarter 2011 Financial Results 2PDL BioPharma Announces Third Quarter 2011 Financial Results 3PDL BioPharma Announces Third Quarter 2011 Financial Results 4PDL BioPharma Announces Third Quarter 2011 Financial Results 5PDL BioPharma Announces Third Quarter 2011 Financial Results 6PDL BioPharma Announces Third Quarter 2011 Financial Results 7PDL BioPharma Announces Third Quarter 2011 Financial Results 8PDL BioPharma Announces Third Quarter 2011 Financial Results 9PDL BioPharma Announces Third Quarter 2011 Financial Results 10PDL BioPharma Announces Third Quarter 2011 Financial Results 11Upgraded ACCF/ AHA/ SCAI Guidelines Reinforce Benefits of Volcano's Precision Guided Therapy Technologies 2Upgraded ACCF/ AHA/ SCAI Guidelines Reinforce Benefits of Volcano's Precision Guided Therapy Technologies 3
(Date:5/20/2013)... 2013) Research presented at Digestive Disease Week (DDW) ... diarrhea (IBS-D) and hepatitis C. , An international ... In the phase II study, researchers found that the ... percent of the individuals treated. , "While there,s ... with constipation, we haven,t seen the same in IBS ...
(Date:5/20/2013)... disease (IBD) are at higher risk of melanoma, a ... Researchers found that IBD is associated with a 37 ... presented at the Digestive Disease Week 2013 conference in ... Crohn,s disease or ulcerative colitis (UC), the most common ... lining of the intestine, leading to bouts of watery ...
(Date:5/20/2013)... novel service for personalized research counseling was launched recently by ... field of providing expert research support services since a decade. ... to maintain a direct contact with mentors and get customized ... at $1000. , Students who opt for the new service ... will handle all aspects. Scholars will be assisted for choosing ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Maui’d Forever is ... and coordinator. Founded in 2003 by entrepreneur Mark Steffan, the ... and the Big Island of Hawaii. They use over 150 ... additional members to their team. , They are happy to ... Chef Kathy Morris. Kathy is an extraordinary chef and is ...
(Date:5/20/2013)... 2013 Main Virtual Office , ... with several Mathnasium franchisee's to provide live answering services ... can we answer and transfer their calls according to ... scheduling at a fraction of what they were being ... Main Virtual Office. "Core competency is critical" says ...
Breaking Medicine News(10 mins):Health News:Pharmaceutical advances offer new options for health outcomes 2Health News:Dissertation Clinic Prescribes Customized Remedy for Researchers 2Health News:Maui'd Forever Uses New Chef for Receptions and Special Private Beach Dinners 2Health News:Virtual Assistant and Mobile App Company - Main Virtual Office - Signs Up Several New Mathnasium Tutoring Centers 2
... updates the NCCN Guidelines for Non-Small Cell Lung Cancer to ... specific patients with Non-Small Cell Lung Cancer, and a revised ... National Comprehensive Cancer Network (NCCN) recently updated the ... a new section about maintenance therapy, a number of new ...
... Convention and Preconvention Program, the only medical imaging conference ... medical ultrasound, to be held March 24-27, 2010, in ... emerging applications and unique opportunities for collaboration between physicians, ... and expand into new arenas. With a ...
... the number of children diagnosed with autistic spectrum disorders over ... have found a sharp difference between the beliefs of ordinary ... incidence of autism. Expert consensus is that the rapid ... many lay people directly or indirectly affected by the disorder ...
... Group evaluated the achievements at EU level in combating ... EU cannot turn its back on CVD", expressed Dirk ... the MEP Heart Group. There is overwhelming evidence that ... It is therefore the task of decision makers at ...
... of vitamin E in the nuts, expert says , WEDNESDAY, ... reduce your risk for lung cancer and other malignancies, according ... of a type of vitamin E called gamma-tocopherol. , "It ... against certain forms of cancer. Higher intakes of gamma-tocopherol ... ...
... CORD:USE Cord Blood Bank is proud to announce that ... Department of Health and Human Services has awarded CORD:USE Cord ... supply of cord blood units for the National Cord Blood ... a prestigious designation which further validates the procedures and operations ...
Cached Medicine News:Health News:NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy 2Health News:NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy 3Health News:AIUM gears up for 2010 Annual Convention in San Diego, Calif. 2Health News:People affected by autism believe increase is 'real,' not diagnostic 2Health News:Want to Cut Cancer Risk? Try Munching Pistachios 2Health News:CORD:USE Cord Blood Bank Receives Grant From HRSA to Increase the National Cord Blood Inventory 2
... Preserve your data for future generations. Most ... the solid backing plate of our gel dryer, ... a frame over them to hold the cellophane ... a frame with an open area somewhat larger ...
... your data for future generations. Most gels can ... backing plate of our gel dryer, covering them ... over them to hold the cellophane flat. Tut's ... with an open area somewhat larger than the ...
... Dryer incorporates sturdy metal housing and TEFLON coated heating ... area makes it perfect for drying down large sequencing ... 40cm x 50cm (W x D) work surface ... you to optimize your heating to your gel ...
... compact air gel-drying system, Hoefers Easy Breeze can dry ... cm) or 24 Mini-Gels (8 x 10 cm) at ... an open air drying oven, a specially designed loading ... no cold trap, no awkward connections., The Gel Frame ...
Medicine Products: